UK markets close in 6 hours 8 minutes

GSK Aug 2022 42.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.03000.0000 (0.00%)
As of 10:07AM EDT. Market open.
Full screen
Previous close0.0300
Open0.0300
Bid0.0000
Ask0.0000
Strike42.00
Expiry date2022-08-19
Day's range0.0300 - 0.0300
Contract rangeN/A
Volume10
Open interestN/A
  • Yahoo Finance Video

    Plaintiff drops suit in first Zantac trial

    Yahoo Finance health care correspondent Anjalee Khemlani details how the first case against pharmaceutical company GSK over its Zantac derivative was voluntarily dismissed.

  • Reuters

    Plaintiff in first Zantac lawsuit set for trial drops case

    The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants. Tuesday's news came days after shares of GlaxoSmithKline Plc, Sanofi SA, Pfizer Inc and Haleon Plc were hit by mounting investor concern about thousands of lawsuits claiming the drug, which U.S. regulators pulled from the market in 2020, causes cancer. The plaintiff, Joseph Bayer, alleged he developed esophageal cancer from taking over-the-counter Zantac.

  • Zacks

    Gilead (GILD) Announces Positive Data on Breast Cancer Drug

    Gilead (GILD) breast cancer drug Trodelvy improves overall survival in pre-treated HR+/HER2- metastatic breast cancer patients. The company will also acquire the remaining rights to the drug.